CASTELLI, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 1.333
EU - Europa 283
AS - Asia 227
OC - Oceania 2
AF - Africa 1
Totale 1.846
Nazione #
US - Stati Uniti d'America 1.332
CN - Cina 150
DE - Germania 92
SG - Singapore 59
IT - Italia 52
FI - Finlandia 42
SE - Svezia 35
GB - Regno Unito 32
FR - Francia 12
IN - India 5
HK - Hong Kong 3
NL - Olanda 3
AU - Australia 2
IE - Irlanda 2
RU - Federazione Russa 2
TR - Turchia 2
UA - Ucraina 2
AT - Austria 1
BE - Belgio 1
BY - Bielorussia 1
CH - Svizzera 1
DK - Danimarca 1
ES - Italia 1
HU - Ungheria 1
ID - Indonesia 1
JP - Giappone 1
KW - Kuwait 1
LK - Sri Lanka 1
MX - Messico 1
NG - Nigeria 1
NO - Norvegia 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
TW - Taiwan 1
VN - Vietnam 1
Totale 1.846
Città #
Houston 166
Woodbridge 159
Chandler 153
Fairfield 145
Ashburn 84
Ann Arbor 82
Cambridge 64
Wilmington 61
Seattle 48
Singapore 46
Beijing 43
Boardman 38
Des Moines 27
Princeton 25
Santa Clara 24
Helsinki 21
Medford 20
Nanjing 17
San Diego 17
Padova 13
Jacksonville 11
Falls Church 10
New York 9
Nürnberg 9
Redwood City 8
Guangzhou 7
Nanchang 7
Cagliari 6
Changsha 6
Jinan 6
Roxbury 6
Shenyang 6
Jiaxing 5
Hangzhou 4
Phoenix 4
Detroit 3
Fermo 3
Haikou 3
Hebei 3
Hong Kong 3
London 3
Ningbo 3
Norwalk 3
Ankara 2
Dublin 2
Hounslow 2
Islington 2
Melbourne 2
Molfetta 2
Paris 2
Rome 2
Rosà 2
Taizhou 2
Wuhan 2
Zhengzhou 2
Acton 1
Amsterdam 1
Baotou 1
Bologna 1
Bordeaux 1
Borås 1
Brookline 1
Brussels 1
Chicago 1
Dallas 1
Dambulla 1
Duncan 1
Dunfermline 1
Edinburgh 1
Fulham 1
Fuzhou 1
Grammichele 1
Hefei 1
Jakarta 1
Krefeld 1
Kuwait City 1
Lagos 1
Lahore 1
Lisbon 1
Los Angeles 1
Manila 1
Milan 1
Minsk 1
Montalto di Castro 1
Pisa 1
Portland 1
Pune 1
Santa Lucia Di Piave 1
Shanghai 1
Simi Valley 1
Taipei 1
Taiyuan 1
Tappahannock 1
Tokyo 1
Venezia 1
Vigodarzere 1
Washington 1
Zurich 1
Totale 1.448
Nome #
Peculiar whole blood rotation thromboelastometry (Rotem) profile in 40 sideropenic anaemia patients 173
Cortactin, another player in the Lyn signaling pathway, is overexpressed and alternatively spliced in leukemic cells from patients with B-cell Chronic Lymphocytic Leukemia. 156
Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia 130
Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival 129
Azathioprine in isolated recurrent pericarditis: A single centre experience 109
Favourable outcome of young patient with t-MDS secondary to breast cancer treatment using azacitidine as induction therapy before allo-BMT 108
Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. 107
Bendamustine in chronic lymphocytic leukemia: Outcome according to different clinical and biological prognostic factors in the everyday clinical practice. 92
CLL patients carrying 13q deletion show clinical heterogenity according to IGVH mutational status and CD38 expression 91
Increased Survival and Migration of CLL B-Cells in the Presence of Marrow Mesenchymal Stromal Cells: Novel Findings for Microenvironment-Targeted Therapies 85
Non-hepatosplenic extramedullary haematopoiesis in primary myelofibrosis 84
Bortezomib-Dexamethasone As Inducion Therapy for Light Chain Deposition Disease (LCDD): A Single Center Experience 67
B cells from Chronic Lymphocytic Leukemia undergo apoptosis following microtubule depolymerization by nocodazole 66
INCREASED SURVIVAL OF CLL B CELLS IN THE PRESENCE OF MARROW MESENCHYMAL STROMAL CELLS: A NOVEL MODEL TO DEFINE NEW TARGETS FOR THERAPY 62
Evaluation of new prognosis marker in B-CLL 61
Microparticles plasma levels in women with venous thromboembolism and cancer 58
Comparative phenotypic analysis of NK receptors on 25 CP-CML patients with sustained complete molecular response (CMR) and major molecular response (MMR) 54
CLL patients with low-risk cytogenetic abnormalities show clinical heterogeneity according to IGVH mutational status and CD38 expression 54
Impact of comorbidity on treatment with 5-azacitidine and outcome in 39 patients with myelodysplastic syndrome: a single center population analysis 51
Thrombin generation and microparticles plasma levels in patients with vasculitis 46
Bendamustina in Chronic Lymphocytic Leukemia (CLL): Outcome According to Different Clinical and Biological Prognostic Factos in Everyday Practica 42
Prospective enrollment of patients with chronic lymphocytic leukemia in a regional registry (CLL Veneto): how unselected patients present to our center 42
Totale 1.867
Categoria #
all - tutte 6.753
article - articoli 6.158
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.911


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020187 0 0 0 0 0 0 26 36 32 52 29 12
2020/2021185 7 21 2 17 10 13 4 22 17 21 39 12
2021/2022286 3 24 23 47 13 27 5 32 16 4 18 74
2022/2023307 48 42 13 45 42 37 2 21 36 4 15 2
2023/2024131 5 23 15 8 19 21 3 11 4 5 5 12
2024/2025170 1 29 31 28 60 20 1 0 0 0 0 0
Totale 1.867